DRAFT - Creative Imagery Document Open for Consultation
-
Announcing PAAB's Draft Creative Imagery in Health Professional Directed Pharmaceutical Advertising
@Manufacturer @Agency we are pleased to announce the release of the DRAFT Creative Imagery in Health Professional Directed Pharmaceutical Advertising, a culmination of dedicated efforts by the Creative Imagery Committee to support the development of creative within the pharmaceutical industry.
Stakeholder Feedback Invited Until December 2nd
The draft guidance document is now live and open for comments from all stakeholders until December 2nd. We highly encourage industry professionals, healthcare providers, and other interested parties to review the document and share their valuable feedback.
How to Access and Comment
• Access the Draft Document: HTML or PDF
• Submit Your Feedback: Please send your comments to info@paab.caOur aim is to finalize the guidance document by the end of 2024. This comprehensive resource will assist the industry in developing creative imagery that is both engaging and compliant with regulatory standards, ultimately enhancing the quality and credibility of pharmaceutical advertising.
Next Steps After the Comment Period
Following the conclusion of the comment period, the PAAB will consolidate all feedback and present it anonymously to the committee. This ensures an unbiased review process where every suggestion is considered equally. The committee will then deliberate on the feedback to make any necessary adjustments to the guidance document.Your insights are crucial in shaping a guidance document that reflects the needs and perspectives of all stakeholders. Together, we can foster an environment of innovation and compliance in pharmaceutical advertising.
For any questions or additional information, please contact us at info@paab.ca.
